Sameed M. Siddiqui

Sameed M. Siddiqui

Auto-generated profile, based on publicly available information

Sameed M. Siddiqui

Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2025 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
SSSameed M. Siddiqui
Sameed M. Siddiqui
NWNicole L. Welch
Nicole L. Welch
TNTien G. Nguyen
Tien G. Nguyen
ARAmaya Razmi
Amaya Razmi
TCTianyi Chang
Tianyi Chang
CMCameron Myhrvold
Cameron Myhrvold
CRISPR-based diagnostics have emerged as a promising tool for fast, accurate and portable pathogen detection. There has been rapid progress in pre-amplification processes and CRISPR-related enzymes used in these approaches, but the development of reporter systems and reaction platforms has lagged behind. In this paper, we develop bead-based techniques to address these gaps. First, we develop a novel bead-based split-luciferase reporter system with up to 20× sensitivity compared with standard fluorescence-based reporter design in CRISPR diagnostics. Second, we develop a highly deployable, bead-based platform capable of detecting nine distinct viral targets in parallelized, droplet-based reactions, with sensitivity reaching as low as 2.5 copies per µl of input RNA. We demonstrate the enhanced performance of both approaches on synthetic and clinical sample sensitivity, speed, multiplexing and deployability.

6 November 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Eric James NillesEric James Nilles
Eric James Nilles
SSSameed M. Siddiqui
Sameed M. Siddiqui
SFStephanie Fischinger
Stephanie Fischinger
YBYannic C. Bartsch
Yannic C. Bartsch
MAMichael de St. Aubin
Michael de St. Aubin
AMAnil S. Menon
Anil S. Menon
Obesity is a key correlate of severe SARS-CoV-2 outcomes while the role of obesity on risk of SARS-CoV-2 infection, symptom phenotype, and immune response remain poorly defined. We examined data from a prospective SARS-CoV-2 cohort study to address these questions. Serostatus, body mass index, demographics, comorbidities, and prior COVID-19 compatible symptoms were assessed at baseline and serostatus and symptoms monthly thereafter. SARS-CoV-2 immunoassays included an IgG ELISA targeting the spike RBD, multiarray Luminex targeting 20 viral antigens, pseudovirus neutralization, and T cell ELISPOT assays. Our results from a large prospective SARS-CoV-2 cohort study indicate symptom phenotype is strongly influenced by obesity among younger but not older age groups; we did not identify evidence to suggest obese individuals are at higher risk of SARS-CoV-2 infection; and remarkably homogenous immune activity across BMI categories suggests immune protection across these groups may be similar.

10 February 2022 in PLOS Biology
Verified
Journal Article
Open access
PDF file
EFEmilie Finch
Emilie Finch
RLRachel Lowe
Rachel Lowe
SFStephanie Fischinger
Stephanie Fischinger
MAMichael de St Aubin
Michael de St Aubin
SSSameed M. Siddiqui
Sameed M. Siddiqui
AKAdam J. Kucharski
Adam J. Kucharski
Identifying the potential for SARS-CoV-2 reinfection is crucial for understanding possible long-term epidemic dynamics. We analysed longitudinal PCR and serological testing data from a prospective cohort of 4,411 United States employees in 4 states between April 2020 and February 2021. We conducted a multivariable logistic regression investigating the association between baseline serological status and subsequent PCR test result in order to calculate an odds ratio for reinfection. We estimated an odds ratio for reinfection ranging from 0.14 (95% CI: 0.019 to 0.63) to 0.28 (95% CI: 0.05 to 1.1), implying that the presence of SARS-CoV-2 antibodies at baseline is associated with around 72% to 86% reduced odds of a subsequent PCR positive test based on our point estimates. This suggests that primary infection with SARS-CoV-2 provides protection against reinfection in the majority of individuals, at least over a 6-month time period. We also highlight 2 major sources of bias and uncertainty to be considered when estimating the relative risk of reinfection, confounders and the choice of baseline time point, and show how to account for both in reinfection analysis.

20 March 2025 in arXiv
Verified
Preprint
Open access
PDF file
KRKrithik Ramesh
Krithik Ramesh
SSSameed M. Siddiqui
Sameed M. Siddiqui
AGAlbert Gu
Albert Gu
MMMichael D. Mitzenmacher
Michael D. Mitzenmacher
PSPardis C Sabeti
Pardis C Sabeti
Deep learning architectures such as convolutional neural networks and Transformers have revolutionized biological sequence modeling, with recent advances driven by scaling up foundation and task-specific models. The computational resources and large datasets required, however, limit their applicability in biological contexts. We introduce Lyra, a subquadratic architecture for sequence modeling, grounded in the biological framework of epistasis for understanding sequence-to-function relationships. Mathematically, we demonstrate that state space models efficiently capture global epistatic interactions and combine them with projected gated convolutions for modeling local relationships. We demonstrate that Lyra is performant across over 100 wide-ranging biological tasks, achieving state-of-the-art (SOTA) performance in many key areas, including protein fitness landscape prediction, biophysical property prediction (e.g. disordered protein region functions) peptide engineering applications (e.g. antibody binding, cell-penetrating peptide prediction), RNA structure analysis, RNA function prediction, and CRISPR guide design. It achieves this with orders-of-magnitude improvements in inference speed and reduction in parameters (up to 120,000-fold in our tests) compared to recent biology foundation models. Using Lyra, we were able to train and run every task in this study on two or fewer GPUs in under two hours, democratizing access to biological sequence modeling at SOTA performance, with potential applications to many fields.